SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending amid retail investor speculation around potential government contracts and congressional stock purchase disclosures, fueling comparisons to Palantir. Bullish investors are actively discussing chart patterns, potential short squeezes, and the company's AI-driven solutions. The community's positive sentiment is centered on potential gains amidst growing interest in AI for defense and security.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around recent token burns and upcoming listings, emphasizing the project's resilience and long-term vision. Community members are actively discussing buy-backs and expressing excitement about future developments, viewing the project as an underdog with strong growth potential within the Solana ecosystem. The focus remains on community strength and continued progress despite market dips.

Turbo Energy SA provides energy solutions. It engages in the developing, manufacturing and distributing of photovoltaic products. The company was founded on September 18, 2013 and is headquartered in Valencia, Spain.

Turbo Energy S.A. - ADR

TURB is trending due to a recent $53 million contract for solar storage deployment, sparking significant community interest and bullish sentiment. The community highlights the stock's nano float and potential for a short squeeze, drawing comparisons to other high-momentum plays. Broader interest in solar energy and energy storage solutions seems to be contributing to the stock's upward movement.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia ($JMIA) is trending following an RBC Capital upgrade citing supply and order growth, coupled with easing currency headwinds. Community chatter suggests excitement around potential short squeeze, while others urge caution amidst rapid gains. Overall, the upgrade has boosted optimism for Jumia's growth prospects in the African e-commerce market.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

COIN is trending as investors react to Google's new payments protocol partnership with Coinbase. Community members are actively discussing potential price movements and whether the stock will experience a short squeeze. Some traders are comparing the current situation to past market behaviors, such as Tesla's stock movements.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending downwards due to an analyst downgrade and concerns about slowing growth. Community sentiment is divided with some viewing the dip as an oversold buying opportunity, while others believe it's a value trap. Discussions also involve competition from major players like Amazon and potential impacts from Walmart ending its exclusivity deal.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending due to a recently announced $750 million ATM offering, sparking concerns about dilution among investors, while others view it as a strategic move to fund growth and potential acquisitions. Community discussion revolves around the timing of the offering, its potential impact on the stock price, and whether it signals upcoming news or strategic moves by the company. Despite the short-term uncertainty, some investors remain confident in Rocket Lab's long-term prospects and leadership.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending amid discussions around its recent leadership appointment and potential impact on global expansion. Community members are actively debating market volatility, dip-buying opportunities, and possible short attacks, while some caution about potential dilution. Bullish sentiment remains strong, with many anticipating a continued upward trend and focusing on the company's upcoming earnings report.

FGI Industries Ltd. engages in the supply of kitchen and bath products. Its products fall under the following categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The Sanitaryware category offers bath products such as toilets, sinks, pedestals and toilet seats. The Bath Furniture category deals with wood and wood-substitute furniture for bathrooms, including vanities, mirrors, laundry and medicine cabinets, and other storage systems. The Shower Systems category includes a range of shower-related products such as shower walls, shower doors and shower basins. The Others category includes shower door and shower systems products, custom kitchen cabinetry, and other accessory items. The company was founded on May 26, 2021 and is headquartered in East Hanover, NJ.

FGI Industries Ltd

FGI is experiencing high volatility and a trading halt after a significant pre-market surge, reportedly driven by a low float and short squeeze speculation. The community is actively discussing potential price targets and whether the initial run has ended, with some traders cautioning about a potential bear trap. This activity occurs within the context of increased interest in small-cap stocks and potential for high percentage gains.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as investors discuss the potential impact of upcoming congressional hearings related to offshore critical minerals. The community is focused on speculation around possible government funding and regulatory approvals that could benefit the deep-sea mining sector. Despite some skepticism, bullish sentiment persists, fueled by anticipation of significant developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viridian Therapeutics, Inc. (VRDN) Reports Q2 Loss, Misses Revenue Estimates

Viridian Therapeutics (VRDN) delivered earnings and revenue surprises of 0.00% and -48.63%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that a...

Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announces the companys...

Shares of Viridian Therapeutics surged nearly 18% at the open on Monday to a nearly three-week high after the company reported promising trial data for its experimental drug veligrotug, aimed at treating chronic thyroid eye disease (TED).Viridian announced that in a late-stage trial, 56% of veligrotug-treated patients experienced a reduction in proptosis, or abnormal eye bulging, achieving a mean reduction of 2.34 mm.&nbsp;Additionally, 56% of participants reported reduced diplopia, or double vision, with 32% achieving complete resolution.&nbsp;The trial also delivered a 2.9-point mean reduction in inflammatory signs and symptoms from baseline, with the drug being well-tolerated and associated with only mild adverse events.Thyroid eye disease, which causes inflammation and damage to the tissues surrounding the eye, affects an estimated 90 to 300 people per 100,000 in the U.S.Viridian confirmed that it remains on track to submit a marketing application for veligrotug to U.S. regulators in the second half of 2025.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VRDN_sentiment_and_message_volume_Dec_16_bd76e824a8.png" alt="VRDN sentiment and message volume Dec 16.png" width="1318" height="324"><figcaption>VRDN sentiment and message volume Dec 16 as of 9:30 am ET | source: Stocktwits</figcaption></figure>On Stocktwits, sentiment for Viridian’s stock turned ‘extremely bullish’, with the ticker entering the platform’s top 15 trending symbols.&nbsp;One user described the news as making the stock a “long-term hold for me.”&nbsp;Another hinted that veligrotug could offer better returns for Viridian than Tepezza, an FDA-approved TED drug marketed by Horizon Therapeutics, which was acquired by Amgen in October 2023 for $27.8 billion.Viridian also expressed optimism about its VRDN-003 program, an IGF-1R antibody in development for TED.&nbsp;The company said the combined results from the THRIVE and THRIVE-2 trials bolster confidence that VRDN-003 will deliver positive topline data by the first half of 2026, enabling a BLA submission in the second half of the same year.&nbsp;Still, Viridian stock remains down about 20% year-to-date, as of its last close.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Viridian Therapeutics Stock Hits 3-Week High, Retail Buzz Builds On Chronic Thyroid Eye Disease Trial Data

The company confirmed that it remains on track to submit a marketing application for veligrotug to U.S. regulators in the second half of 2025.

Equity

The company confirmed that it remains on track to submit a marketing application for veligrotug to U.S. regulators in the second half of 2025.


Viridian Therapeutics Announces Positive Topline Results from Veligrotug Phase 3 THRIVE-2 Clinical Trial in Patients with Chronic Thyroid Eye Disease

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced positive...

Viridian Therapeutics to Webcast Veligrotug Phase 3 THRIVE-2 Topline Results on December 16, 2024

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced plans to...

Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent...

Viridian Therapeutics, Inc. (Nasdaq: VRDN) (the company or Viridian), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare...

Analyst Expectations For Viridian Therapeutics's Future

Latest Ratings for VRDN
 DateFirmActionFromTo Mar 2022JMP SecuritiesMaintainsMarket Outperform Nov 2021SVB LeerinkInitiates Coverage OnOutperform Nov 2021JMP SecuritiesMaintainsMarket Outperform...

Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

Hike 25 bps

It’s Fed Decision Week. Polymarket gives a 90% chance of a 25 bps cut. What’s your call? 
 
*Powered by Polymarket

VRDN
Viridian Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest VRDN News

VRDN Viridian Therapeutics Inc